~$1.8B
Medical devices market 2026
#2
GCC device market after Saudi
~95%
Import dependence
3–6 mo
MOHAP device registration
UAE Medical Device Market Overview
The UAE is the GCC's second-largest medical device market at approximately US$1.8 billion in 2026, growing around 8% annually on medical tourism, insurance expansion, and hospital investment. Around 95% of devices are imported, and Dubai's logistics infrastructure makes the UAE the re-export hub for the wider Middle East and Africa.
Regulation is federal plus emirate-level: MOHAP registers medical devices nationally (typically 3–6 months with FDA/CE reference approvals), while DHA (Dubai) and DOH (Abu Dhabi) license facilities and govern local procurement channels. Mandatory health insurance in Dubai and Abu Dhabi funds a predominantly private provision model.
The provider landscape splits between government systems (SEHA/PureHealth in Abu Dhabi, Dubai Health, Emirates Health Services federally) and premium private groups (Mediclinic, NMC, Aster, American Hospital, Cleveland Clinic Abu Dhabi) — each with distinct procurement behaviour that distributors like Gulf Drug, Al Zahrawi, and AMICO navigate.
Top Medical Device Companies in the UAE
The following table lists the major medical device companies operating in the UAE — including local manufacturers, multinational offices, regional players, and leading distributors.
| Company | HQ |
|---|---|
| Medtronic META | USA / Ireland |
| GE HealthCare | USA |
| Siemens Healthineers | Germany |
| Philips Healthcare | Netherlands |
| Johnson & Johnson MedTech | USA |
| Abbott | USA |
| Roche Diagnostics | Switzerland |
| Stryker | USA |
| Boston Scientific | USA |
| B. Braun | Germany |
| BD | USA |
| Dräger | Germany |
| Mindray | China |
| Gulf Drug LLC | UAE |
| Al Zahrawi Medical | UAE |
| AMICO Group | UAE / Saudi Arabia |
| Al Maqam Medical Supplies | UAE |
| Bin Sina / Alphamed network | UAE |
| Burjeel/VPS biomedical procurement arms | UAE |
Planning research in UAE?
Primary research, market access & HEOR. Proposals within 48 hours.
BioNixus market research
Commission custom UAE fieldwork
Book a 30-minute briefing to align on MOHAP pathway intelligence, stakeholder mapping, and competitive tracking for the UAE.
List of Medical Device Companies in the UAE by Category
UAE medical device companies span local manufacturers, multinational corporation offices, regional suppliers, and key distributors.
Local Manufacturers
Local manufacturing is minimal; Dubai Science Park and Abu Dhabi industrial strategy are attracting assembly and consumables ventures.
Multinational Offices
Global manufacturers dominate and typically run Middle East regional HQs from Dubai — Medtronic, GE, Siemens Healthineers, Philips, J&J MedTech, Abbott, Roche Diagnostics, Stryker, Boston Scientific, B. Braun, BD, Dräger, and Mindray.
- ✓ Medtronic META
- ✓ GE HealthCare
- ✓ Siemens Healthineers
- ✓ Philips Healthcare
- ✓ Johnson & Johnson MedTech
- ✓ Abbott
- ✓ Roche Diagnostics
- ✓ Stryker
- ✓ Boston Scientific
- ✓ B. Braun
- ✓ BD
- ✓ Dräger
- ✓ Mindray
Regional Players
Provider-side purchasing groups (PureHealth, Burjeel/VPS) increasingly centralise demand across their hospital networks.
- ✓ Burjeel/VPS biomedical procurement arms
Distributors
Gulf Drug, Al Zahrawi, AMICO, and Al Maqam anchor distribution, handling MOHAP registration, tender access, and service across all seven emirates.
- ✓ Gulf Drug LLC
- ✓ Al Zahrawi Medical
- ✓ AMICO Group
- ✓ Al Maqam Medical Supplies
- ✓ Bin Sina / Alphamed network
Medical Device Companies in the UAE: MOHAP Regulatory Landscape
Ministry of Health and Prevention (with DHA Dubai and DOH Abu Dhabi) is the UAE's medical device regulator.
Regulatory Authority
Ministry of Health and Prevention (with DHA Dubai and DOH Abu Dhabi) (MOHAP) oversees registration, quality control, pricing, vigilance, and import licensing.
Registration Timeline
3–6 months
Renewal Period
5 years
Pricing Model
No formal device price control; insurance reimbursement and group purchasing set effective prices
Key Registration Requirements
- ✓MOHAP medical device registration with local authorised representative
- ✓Reference approvals (FDA, CE MDR, TGA, Health Canada, PMDA) accepted
- ✓Free Sale Certificate and ISO 13485 evidence
- ✓English/Arabic labelling requirements
- ✓DHA/DOH facility-level requirements for emirate channels
- ✓Separate SEHA-PureHealth / Dubai Health group tender registration
Market Access Note
MOHAP registration is fast with reference approvals — the commercial work is channel-specific: PureHealth group purchasing in Abu Dhabi, Dubai Health and private-group procurement in Dubai, and insurance (Thiqa/Daman, DHA-mandated plans) reimbursement for consumables and diagnostics.
UAE Medical Device Market Growth Drivers
Medical Tourism Expansion
Dubai and Abu Dhabi target multi-million annual medical tourists, driving premium equipment adoption in private groups.
Mandatory Insurance Depth
Universal mandatory insurance in Abu Dhabi and Dubai (and rollout across other emirates) funds procedure and diagnostics volume.
Regional HQ Concentration
Middle East pricing, tender, and portfolio decisions concentrate in Dubai offices — regional strategy is set in the UAE.
PureHealth Consolidation
PureHealth's roll-up of SEHA, Daman, and private assets creates the region's largest integrated purchaser.
Digital & AI Health Adoption
National AI strategy and smart-hospital programmes accelerate connected device and imaging-AI uptake.
Re-Export Hub Role
Jebel Ali logistics make the UAE the distribution base for Levant, Africa, and CIS device flows.
How BioNixus Supports Medical Device Companies in the UAE
BioNixus is a healthcare market research company with primary-research capability in the UAE and cross-market benchmarking against GCC, USA, and European markets. We help pharma, biotech, and medtech companies with:
Hospital Procurement Research
Purchasing-committee research across SEHA/PureHealth, Dubai Health, and private groups (Mediclinic, Burjeel, Aster, NMC).
Market Access & MOHAP Strategy
Registration pathway analysis, distributor due diligence, and insurance reimbursement mapping.
KOL & Clinician Studies
Fieldwork with UAE surgeons, radiologists, and lab directors across government and private channels.
GCC Benchmarking
UAE vs Saudi/Qatar/Kuwait sizing, pricing corridors, and tender-calendar intelligence.
Frequently Asked Questions
What are the top medical device companies in the UAE?
The market is led by multinationals running Dubai regional HQs — Medtronic, GE HealthCare, Siemens Healthineers, Philips, J&J MedTech, Abbott, Roche Diagnostics, Stryker, Boston Scientific, B. Braun, BD, and Dräger — distributed by Gulf Drug, Al Zahrawi Medical, AMICO, and Al Maqam.
What is the size of the UAE medical device market?
The UAE medical device market is valued at approximately US$1.8 billion in 2026, growing ~8% annually — the GCC's second-largest after Saudi Arabia, with ~95% import dependence.
How do you register a medical device in the UAE?
Foreign manufacturers appoint a UAE authorised representative and register with MOHAP, leveraging FDA/CE/TGA reference approvals — typically 3–6 months. Facility-level requirements from DHA (Dubai) and DOH (Abu Dhabi) apply to the provider channels.
Who buys medical devices in the UAE?
Public channels: PureHealth/SEHA (Abu Dhabi), Dubai Health, and Emirates Health Services (northern emirates). Private channels: Mediclinic, Burjeel/VPS, Aster, NMC, American Hospital, and Cleveland Clinic Abu Dhabi. Group purchasing is consolidating on both sides.
Why do medtech companies base regional HQs in Dubai?
Connectivity, talent, free-zone incentives (DAFZA, Dubai Science Park, JAFZA), and proximity to the Saudi market. Middle East, Turkey & Africa portfolio and pricing decisions are typically governed from Dubai offices.
Is the UAE a good GCC entry market for devices?
Yes — fast MOHAP registration, premium private adoption, and regional HQ visibility make the UAE a common first GCC launch, with Saudi Arabia following as the volume market via SFDA/NUPCO.
Data Sources & Methodology
This guide aggregates publicly available information from:
- MOHAP medical device registration guidance
- DHA / DOH regulatory publications
- PureHealth and provider-group announcements
- Trade and company data
- BioNixus proprietary research (UAE & GCC, 2024–2026)
Company lists are editorial snapshots, not endorsements; market sizes are BioNixus estimate ranges synthesised from regulator and industry sources. For customised market intelligence on the UAE, contact our team.